Physician profile
Mohammad Daaif
NPI 1720271331
$897.76
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $415 · 2020: $157 · 2021: $121 · 2022: $185 · 2023: $19.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $159.40 | 2019-2022 | |
| Celgene Corporation | $148.94 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $99.65 | 2019-2020 | |
| Adamas Pharmaceuticals, INC. | $70.06 | 2019-2020 | |
| Livanova USA, INC. | $38.35 | 2019-2020 | |
| Biogen, INC. | $33.41 | 2019 | |
| Abbvie INC. | $32.61 | 2022-2023 | Botox |
| Novartis Pharmaceuticals Corporation | $29.95 | 2019 | |
| Portola Pharmaceuticals, LLC | $25.64 | 2019 | |
| Allergan, INC. | $23.73 | 2020 | |
| Emd Serono, INC. | $23.02 | 2019 | |
| Ucb, INC. | $22.61 | 2019 | |
| Abbott Laboratories | $20.20 | 2020 | |
| Acorda Therapeutics, INC | $20.04 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $20.00 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $19.68 | 2020 | |
| Acadia Pharmaceuticals INC | $16.05 | 2020 | |
| Greenwich Biosciences, INC. | $15.95 | 2019 | |
| Amneal Pharmaceuticals LLC | $15.40 | 2021 | |
| Boston Scientific Corporation | $14.89 | 2019 | |
| Alexion Pharmaceuticals, INC. | $13.88 | 2020 | |
| Genentech USA, INC. | $11.65 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.56 | 2019 | |
| Mdd US Operations, LLC | $11.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Daaif listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.